489 related articles for article (PubMed ID: 30639526)
1. Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports.
Jeong W; Keighley C; Wolfe R; Lee WL; Slavin MA; Chen SC; Kong DCM
Int J Antimicrob Agents; 2019 May; 53(5):589-597. PubMed ID: 30639526
[TBL] [Abstract][Full Text] [Related]
2. Mucormycosis: New Developments into a Persistently Devastating Infection.
Danion F; Aguilar C; Catherinot E; Alanio A; DeWolf S; Lortholary O; Lanternier F
Semin Respir Crit Care Med; 2015 Oct; 36(5):692-705. PubMed ID: 26398536
[TBL] [Abstract][Full Text] [Related]
3. Mucormycosis treatment: Recommendations, latest advances, and perspectives.
Brunet K; Rammaert B
J Mycol Med; 2020 Sep; 30(3):101007. PubMed ID: 32718789
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia.
Rickerts V; Atta J; Herrmann S; Jacobi V; Lambrecht E; Bialek R; Just-Nübling G
Mycoses; 2006; 49 Suppl 1():27-30. PubMed ID: 16961579
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary mucormycosis: report of 5 cases and review of 46 cases reported in China].
Yang YM; Fang BM; Xu XM; Fang F; Pan MM; Zhong XF; Sun TY
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):572-6. PubMed ID: 24252732
[TBL] [Abstract][Full Text] [Related]
6. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
Riley TT; Muzny CA; Swiatlo E; Legendre DP
Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
[TBL] [Abstract][Full Text] [Related]
7. Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).
Salmanton-García J; Seidel D; Koehler P; Mellinghoff SC; Herbrecht R; Klimko N; Ráčil Z; Falces-Romero I; Ingram P; Benítez-Peñuela MÁ; Rodríguez JY; Desoubeaux G; Barać A; García-Vidal C; Hoenigl M; Mehta SR; Cheng MP; Klyasova G; Heinz WJ; Iqbal N; Krause R; Ostermann H; Penack O; Schalk E; Sheppard DC; Willinger B; Wisplinghoff H; Vehreschild JJ; Cornely OA; Vehreschild MJGT;
J Antimicrob Chemother; 2019 Nov; 74(11):3315-3327. PubMed ID: 31393591
[TBL] [Abstract][Full Text] [Related]
8. Disseminated Mucormycosis With Cerebral Involvement Owing to Rhizopus Microsporus in a Kidney Recipient Treated With Combined Liposomal Amphotericin B and Posaconazole Therapy.
Ville S; Talarmin JP; Gaultier-Lintia A; Bouquié R; Sagan C; Le Pape P; Giral M; Morio F
Exp Clin Transplant; 2016 Feb; 14(1):96-9. PubMed ID: 25275881
[TBL] [Abstract][Full Text] [Related]
9. Mucormycosis in Mainland China: A Systematic Review of Case Reports.
Wei LW; Zhu PQ; Chen XQ; Yu J
Mycopathologia; 2022 Feb; 187(1):1-14. PubMed ID: 34855101
[TBL] [Abstract][Full Text] [Related]
10. Treatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents.
Chitasombat MN; Kontoyiannis DP
Curr Opin Infect Dis; 2016 Aug; 29(4):340-5. PubMed ID: 27191199
[TBL] [Abstract][Full Text] [Related]
11. Utility of Itraconazole in Combination with Liposomal Amphotericin B in Rhizopus oryzae Associated Mucormycosis-An Exploratory Study.
Dandu H; Kumar N; Kumar N; Malhotra HS; Prabhu V; Bharti VR; Gupta P; Yadav G; Verma V
Mycopathologia; 2024 Jun; 189(4):54. PubMed ID: 38865003
[TBL] [Abstract][Full Text] [Related]
12. Mucormycosis in renal transplant recipients: review of 174 reported cases.
Song Y; Qiao J; Giovanni G; Liu G; Yang H; Wu J; Chen J
BMC Infect Dis; 2017 Apr; 17(1):283. PubMed ID: 28420334
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases.
Corzo-León DE; Chora-Hernández LD; Rodríguez-Zulueta AP; Walsh TJ
Med Mycol; 2018 Jan; 56(1):29-43. PubMed ID: 28431008
[TBL] [Abstract][Full Text] [Related]
14. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
[TBL] [Abstract][Full Text] [Related]
15. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.
Pana ZD; Seidel D; Skiada A; Groll AH; Petrikkos G; Cornely OA; Roilides E;
BMC Infect Dis; 2016 Nov; 16(1):667. PubMed ID: 27832748
[TBL] [Abstract][Full Text] [Related]
16. Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease.
Mezhir JJ; Mullane KM; Zarling J; Satoskar R; Pai RK; Roggin KK
Surg Infect (Larchmt); 2009 Oct; 10(5):447-51. PubMed ID: 19485785
[TBL] [Abstract][Full Text] [Related]
17. [Mucormycosis: therapeutic news].
Pilmis B; Lanternier F; Lortholary O
Med Sci (Paris); 2013 Mar; 29 Spec No 1():25-30. PubMed ID: 23510522
[TBL] [Abstract][Full Text] [Related]
18. Successful Treatment of Primary Cutaneous Mucormycosis Complicating Anti-TNF Therapy with a Combination of Surgical Debridement and Oral Posaconazole.
Camargo JF; Yakoub D; Cho-Vega JH
Mycopathologia; 2015 Oct; 180(3-4):187-92. PubMed ID: 26112998
[TBL] [Abstract][Full Text] [Related]
19. Cerebral mucormycosis in a diabetic man.
Uy EM; Rustagi T; Khera S
Conn Med; 2011 May; 75(5):273-9. PubMed ID: 21678839
[TBL] [Abstract][Full Text] [Related]
20. Sinonasal mucormycosis: case report.
Mimouni O; Curto CL; Danvin JB; Thomassin JM; Dessi P
Eur Ann Otorhinolaryngol Head Neck Dis; 2010 Mar; 127(1):27-9. PubMed ID: 20822753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
